Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Cefuroxime sodium
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cefuroxime 750mg powder for solution for injection vials
0501021J0AAABAB
|
Cefuroxime sod (Parent) | Cefuroxime sodium | Infections | 14 |
|
Cefuroxime 5% eye drops preservative free
1103010T0AAACAC
|
Cefuroxime sod (Eye) | Cefuroxime sodium | Eye | 4 |
|
Cefuroxime 5% eye drops
1103010T0AAAAAA
|
Cefuroxime sod (Eye) | Cefuroxime sodium | Eye | 2 |
|
Britacef 1.5g powder for solution for injection vials
0501021J0BCACAC
|
Britacef | Cefuroxime sodium | Infections | No data available |
|
Britacef 250mg powder for solution for injection vials
0501021J0BCAAAA
|
Britacef | Cefuroxime sodium | Infections | No data available |
|
Britacef 750mg powder for solution for injection vials
0501021J0BCABAB
|
Britacef | Cefuroxime sodium | Infections | No data available |
|
Cefuroxime 1.5g powder for solution for injection vials
0501021J0AAACAC
|
Cefuroxime sod (Parent) | Cefuroxime sodium | Infections | No data available |
|
Cefuroxime 250mg powder for solution for injection vials
0501021J0AAAAAA
|
Cefuroxime sod (Parent) | Cefuroxime sodium | Infections | No data available |
|
Zinacef 1.5g powder for solution for injection vials
0501021J0BBACAC
|
Zinacef | Cefuroxime sodium | Infections | No data available |
|
Zinacef 250mg powder for solution for injection vials
0501021J0BBAAAA
|
Zinacef | Cefuroxime sodium | Infections | No data available |
|
Zinacef 750mg powder for solution for injection vials
0501021J0BBABAB
|
Zinacef | Cefuroxime sodium | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.